US2019008752A1PendingUtilityA1
Cleansing Compositions
Est. expiryDec 31, 2035(~9.5 yrs left)· nominal 20-yr term from priority
Inventors:Eugene HardyShujiang ChengZeenat NabiJeffrey MastrullEvangelia ArvanitidouLaurence Du-Thumm
A61K 8/466A61K 8/42A61K 8/8164A61K 8/8182A61K 8/442A61K 2800/596A61Q 19/10A61K 8/463A61K 8/44A61K 8/81A61K 8/46
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein, are personal care compositions comprising a surfactant system; an amino acid, e.g. taurine; and a deposition aid comprising a PVM/MA copolymer having a M.W. of from about 30,000 to about 1,000,000, or a vinylimidazolium vinyl pyrrolidone copolymer. Methods of making and using these compositions are also described.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A personal care composition comprising:
a surfactant system; an amino acid; and a deposition aid comprising
a PVM/MA copolymer having a molecular weight (M.W.) of about 30,000 to about 1,000,000, or
a vinylimidazolium vinyl pyrrolidone copolymer.
2 . The personal care composition of claim 1 , wherein the amino acid comprises an amino group and a sulfonic acid group or a carboxy group.
3 . (canceled)
4 . The personal care composition of claim 1 , wherein the amino acid is selected from the group consisting of taurine, arginine, glycine, and a combination of one or more thereof.
5 . (canceled)
6 . (canceled)
7 . The personal care composition of claim 1 , wherein the PVM/MA copolymer has a further polymerizable ethylenically unsaturated monomer; wherein the further polymerizable ethylenically unsaturated monomer comprises methyl vinyl ether (methoxyethylene).
8 . The personal care composition of claim 7 , wherein the PVM/MA copolymer has a molecular weight (M.W.) of from about 300,000 to about 800,000, optionally about 700,000.
9 . The personal care composition of claim 7 , Therein the PVM/MA copolymer is a liquid at room temperature.
10 . The personal care composition of claim 7 , wherein the vinylimidazolium vinyl pyrrolidone copolymer is a vinylimidazolium vinyl-2-pyrrolidone copolymer, for example 1-methyl-3-vinylimidazolium methyl sulfate-N-vinyl-2-pyrrolidone copolymer (Polyquaternium 44).
11 . The personal care composition of claim 1 , wherein the deposition aid is present in the composition in an amount of from 0.01% to 2%, for example from 0.01% to 1%, for example from 0.03% to 1%, for example from 0.05% to 0.08%, for example from 0.06% to 0.07%, by weight of the composition.
12 . The personal care composition of claim 1 , wherein the surfactant system comprises at least one anionic surfactant; at least one zwitterionic surfactant; and at least one nonionic surfactant.
13 . The personal care composition of claim 1 , wherein the surfactant system is present in the composition in an amount of from about 5% to about 30%, for example from about 5% to about 25%, for example from about 10% to about 20%, for example from about 12% to about 18%, for example from about 14% to about 16%, by weight of the composition.
14 . The personal care composition of claim 1 , wherein the surfactant system comprises an anionic surfactant selected from sulfate surfactants; for example sodium laureth sulfate, alpha olefin sulfate, sodium lauryl sarcosinate, sodium pareth sulfate, sodium myreth sulfate, sodium dodecyl sulfate, ammonium lauryl sulfate, and ammonium laureth sulfate; and sulfonate surfactants, for example alkyl sulfonates and alpha olefin sulfonates.
15 . The personal care composition of claim 1 , wherein the surfactant system comprises a zwitterionic surfactant selected from quaternary ammonium carboxylate betaines, for example cocoamidopropyl betaine, and sultaines, for example cocamidopropylhydroxysultaine.
16 . The personal care composition of claim 1 , wherein the surfactant system comprises one or more nonionic surfactants independently selected from polyether surfactants (e.g., PPG-2 hydroxyethyl cocamide), alcohol ethoxylate surfactants (e.g., C12-16 alcohol EO 7:1), fatty acid amide surfactants (e.g., cocamide MEA), and polyoxy ethers of alcohols (e.g., laureth-10), and condensation products of aliphatic (C8-C18) primary or secondary linear branched chain alcohols with alkylene oxides or phenols with alkylene oxides, ethylene oxides and having from 6-to 30 ethylene oxide groups, fatty acid alkanolamides including those having 10-18 carbons, such as for example, coconut fatty acid monoethanolamide and coco mono-isopropanolamide.
17 . The personal care composition of claim 1 , wherein the anionic surfactant is present in the composition in an amount of from about 1% to about 15%, for example from about 2% to about 12%, for example from about 6% to about 10%, for example from about 7% to about 10%, for example from about 8% to about 9%, by weight of the composition.
18 . (canceled)
19 . The personal care composition of claim 15 , wherein the zwitterionic surfactant comprises one or both of cocamidopropyl betaine and oleamidopropyl betaine.
20 . (canceled)
21 . The personal care composition of claim 1 , wherein the surfactant system comprises at least one anionic surfactant; at least one zwitterionic surfactant; and at least one nonionic surfactant; wherein:
the at least one anionic surfactant comprises a sulfate surfactant; for example sodium laureth sulfate; the at least one zwitterionic surfactant comprises a quaternary ammonium carboxylate betaine, for example cocoamidopropyl betaine; and the at least one nonionic surfactant selected from a polyether surfactant, an alcohol ethoxylate surfactant, a fatty acid amide surfactant, and a polyoxy ether of an alcohol.
22 . (canceled)
23 . The personal care composition of claim 1 , wherein taurine is present in the composition in an amount of from about 0.1% to about 5%, for example from about 1% to about 4%, for example from about 2% to about 3%, by weight of the composition.
24 . The personal care composition of claim 1 , wherein the taurine and the deposition aid are present in the composition in a weight ratio of from about 30:1 to about 45:1; or from about 35:1 to about 42:1; of from about 37:1 to about 40:1; or from about 38:1 to about 39:1.
25 . (canceled)
26 . A method for increasing the deposition of an amino acid, e.g. taurine, onto a mammalian skin surface from a personal care composition, comprising the steps of:
formulating a personal care composition comprising taurine and a deposition agent comprising
a PVM/MA copolymer having a M.W. of from about 30,000 to about 1,000,000, or
a vinylimidazolium vinyl pyrrolidone copolymer; and
applying the personal care composition to the skin of a mammal in need thereof.
27 . A method for the preparing a personal care composition comprising combining together in a personal care composition base:
a surfactant system comprising at least one anionic surfactant, at least one zwitterionic surfactant, and at least one nonionic surfactant; an amino acid, e.g., taurine; and a deposition aid comprising
a PVM/MA copolymer having a M.W. of from about 30,000 to about 1,000,000, or
a vinylimidazolium vinyl pyrrolidone copolymer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.